IE
CAMP icon

Israel Englander’s CAMP4 Therapeutics CAMP Stock Holding History

Israel Englander’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
43,903
-42,015
-49% -$181K ﹤0.01% 5335
2026
Q1 		$379K Buy
85,918
+75,816
+751% +$360K ﹤0.01% 4907
2025
Q4 		$61.9K Sell
10,102
-84,969
-89% -$361K ﹤0.01% 5709
2025
Q3 		$285K Sell
95,071
-37,965
-29% -$70.3K ﹤0.01% 5360
2025
Q2 		$193K Buy
+133,036
New +$265K ﹤0.01% 5378

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's CAMP Position: Q2 2026 in Review

Israel Englander reduced its CAMP4 Therapeutics (CAMP) stake by 49% in Q2 2026, selling an estimated $181K and leaving 43,903 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #5335.

Israel Englander first reported a position in CAMP in Q2 2025 and has held it in 5 quarters since. The position peaked at $379K in Q1 2026. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Israel Englander held 43,903 shares of CAMP4 Therapeutics worth $192K as of Q2 2026.
  • Israel Englander sold 42,015 CAMP4 Therapeutics shares in Q2 2026, an estimated $181K.
  • CAMP4 Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5335 holding.
  • Israel Englander first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Israel Englander's CAMP4 Therapeutics position peaked at $379K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.